Databricks, the renowned data and AI company based in San Francisco, recently announced a staggering $1 billion in funding. The company, known for its Data Intelligence Platform used by over 10,000 organizations globally, such as Comcast and Grammarly, aims to unify and democratize data, analytics, and AI for its clients. This significant funding round will further propel Databricks' mission to innovate in the data industry and strengthen its position as a leader in the field. The investment will be pivotal in enhancing their platform's capabilities, expanding their global reach, and driving advancements in data technologies. With this impressive funding milestone, Databricks is well-positioned to continue revolutionizing how businesses leverage data and AI for growth and innovation on a massive scale.
Databricks Secures $1B in Funding to Revolutionize Data and AI: What This Means for the Future of Tech
Recently funded 路 $1.0BSoftware Development
Get the full Databricks company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
